Glioblastoma Therapeutics Network (NCI)

• DOI: http://doi.org/10.1002/fgc.31309
• Date: 17 September 2020
• Published date: 17 September 2020

Page 8 Federal Grants & Contracts ■ September 17, 2020

© 2020 Wiley Periodicals LLC • All rights reserved • DOI: 10.1002/fgc

Grants alert (cont.)

4 EASY WAYS TO ORDER

CALL Toll-Free: 800.835.6770

MAIL:

John Wiley & Sons Inc.

P.O. Box 55381

Boston, MA 02205-9850

EMAIL: cs-journals@wiley.com or

ONLINE AT: wileyonlinelibrary.com/journal/fgc

Wiley Guarantee: If you are not completely satisfied with this newsletter,

let us know and we will refund the cost of your subscription.

❑ YES! Please start my one-year subscription (24 issues) to

Federal Grants and Contracts for $446

PAYMENT OPTIONS: (all payments must be in U.S. dollars)

❑My Check payable to John Wiley & Sons is enclosed.

To make payment by credit card, please contact Customer Service 24 × 7

at +1-800-835-6770.

Name: ___________________________________________

Title: _____________________________________________

Company: _________________________________________

Address: __________________________________________

City: ____________________ State: ___ ZIP Code: ___________

Email: ___________________ Phone: ____________________

❑ Yes, I’d like to hear about special discount offers, new products, and more.

Place me on the Wiley email list.

Individual rate subscriptions must be paid by pe rsonal check or credit card. All orders subject

to credit approval. Price includes postage, packing, and handling charge s worldwide.

Canadian residents add GST and any local sales t ax. GST #128424017.

Individual-rate subscriptions may not be resol d or used as library copies.

Glioblastoma Therapeutics Network (NCI)

Scope: The National Cancer Institute seeks (U19)

research program cooperative agreement applications

for the Glioblastoma Therapeutics Network

announcement to improve the treatment of adult

glioblastoma by developing novel effective agents that

can cross the blood-brain barrier and testing them in the

clinic.

Deadline: Letters of Intent are due 30 days before the

deadline; proposals, Nov. 19, 2020.

Funds: $6 million in FY2021 for four to five awards. The

maximum project period is five years.

Eligibility: Colleges and universities; for-profit

organizations, including small businesses; nonprofit

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: NCI said projects focusing on small molecules

are preferred, and biologic agents that target either the

tumor or the immunosuppressive microenvironment and

that meet the criteria for this concept may be proposed;

research projects may be hypothesis-driven or

hypothesis-generating; and each research project must

be led by a minimum of two co-leaders: one laboratory

scientist and one clinical researcher.

➜ www.grants.gov; FON# RFA-CA-20-047

Research Specialist Award (NCI)

Scope: The National Cancer Institute seeks (R50)

research specialist award applications for the Research

Specialist (Core-based Scientist) Award announcement

to encourage the development of stable research career

opportunities for exceptional scientists who want to

continue to pursue research within the context of an

existing NCI-funded basic, translational, clinical or

population science cancer research program, but not

serve as independent investigators.

Deadline: Letters of Intent are due 30 days before the

deadline; proposals, Jan. 4, 2021.

Funds: The number of awards depends on

appropriations and the submission of a sufficient

number of quality applications. The maximum project

period is five years.

Eligibility: Colleges and universities; for-profit

organizations, including small businesses; nonprofit

organizations; and state, local, special district and Native

American tribal governments; among others.

Areas: NCI said funding is intended to provide salary

support for a sustained period of time and encourage

the development of a stable career for exceptional

researchers who want to continue to support cancer

research within the context of a core/shared resource/

central scientific support. The award is intended

for research-oriented investigators with significant,

relevant experience who have shown clear evidence

of productivity and research excellence in the field of

their training and would like to support a particular

research activity (e.g., core/shared resource/central

scientific support), with the goal of making significant

contributions to behavioral, biomedical (basic or clinical),

computational, bioimaging or bioengineering research

that is relevant to the NCI mission.

➜ www.grants.gov; FON# PAR-20-287 ■